A light-triggerable formulation to control the stability of pro-angiogenic transcription factor hypoxia inducible...

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Nanotechnology

Background:

• Hypoxia-inducible factor 1-alpha (HIF-1α) is crucial for vascular remodeling in diseases like cancer and ischemic heart disease.
• Small interfering RNA (siRNA) gene silencing is a therapeutic strategy for HIF-1α, but current delivery systems lack endothelial targeting and efficiency.

Purpose of the Study:

• To develop a light-triggerable polymeric nanoparticle (NP) library for efficient and targeted siRNA delivery to regulate HIF-1α.
• To identify NP formulations with enhanced endothelial cell targeting and superior gene knockdown efficacy compared to commercial agents.

Main Methods:

• Synthesized a library of 110 light-triggerable polymeric nanoparticles with varying properties.
• Screened NP formulations for siRNA delivery efficiency and gene knockdown of HIF-1α.
• Evaluated the targeting specificity of the most efficient NPs towards endothelial cells using a two-step methodology.

Main Results:

• Over 35% of the NP formulations outperformed commercial transfection agents in gene knockdown.
• Identified a specific NP formulation demonstrating exquisite targeting to endothelial cells.
• The selected NP formulation achieved more efficient siRNA delivery for modulating HIF-1α than commercial agents.

Conclusions:

• The developed light-triggerable NPs offer a promising strategy for targeted gene silencing of HIF-1α.
• This approach significantly enhances intracellular siRNA delivery efficiency and tissue-specific regulation.
• The findings pave the way for improved therapeutic interventions in HIF-1α-related diseases.